PLANTATION, FL, Dec. 2, 2019 /CNW/ - Akumin Inc. (TSX: AKU.U;
AKU) ("Akumin" or the "Corporation") announced that
it has changed its auditors to Ernst & Young LLP. At the
request of the Corporation, PricewaterhouseCoopers LLP, the former
auditors, resigned effective November 29, 2019 and the board
of directors appointed Ernst & Young LLP as the Corporation's
auditor effective December 2, 2019
until the next annual general meeting of the Corporation. The
change of auditor was made in connection with the Corporation's
intention to commence reporting its financial statements in U.S.
GAAP instead of IFRS during the 2020 fiscal year, as discussed at
its annual general meeting of shareholders held June 21, 2019. Prior to the appointment of
Ernst & Young as the successor auditors, the board of directors
approved the addition of U.S. head office for the Corporation in
Plantation, Florida.
Toronto, Ontario would remain the
Canadian head office.
"We would like to thank PricewaterhouseCoopers LLP for their
audit expertise and guidance these past several years and we are
pleased to announce that Ernst & Young LLP will act as our
auditors going forward. We expect to continue to use
PricewaterhouseCoopers for non-audit services," said Riadh Zine, President and Chief Executive
Officer of Akumin.
There were no reservations in PricewaterhouseCoopers LLP's audit
reports for the period commencing at the beginning of Akumin's two
most recent financial years and ending at the date of
PricewaterhouseCoopers' resignation. There are no "reportable
events," as that term is defined in National Instrument 51-102 –
Continuous Disclosure Obligations ("NI 51-102"),
between Akumin and PricewaterhouseCoopers.
In accordance with NI 51-102, the notice of change of auditor,
together with the required letters from the former auditor and the
successor auditor, have been reviewed by the board of directors of
the Company and filed on SEDAR.
About Akumin
Akumin is a leading provider of freestanding, fixed-site
outpatient diagnostic imaging services in the United States with a network of owned
and/or operated imaging centers located in Florida, Texas, Pennsylvania, Delaware, Illinois, Kansas and Georgia. By combining our clinical expertise
with the latest advances in technology and information systems, our
centers provide physicians with imaging capabilities to facilitate
the diagnosis and treatment of diseases and disorders and may
reduce unnecessary invasive procedures, minimizing the cost and
amount of care for patients. Our imaging procedures include MRI,
CT, positron emission tomography (PET), ultrasound, diagnostic
radiology (X-ray), mammography, and other interventional
procedures.
Forward-Looking Information
Certain information in this press release constitutes
forward-looking information. In some cases, but not necessarily in
all cases, forward-looking information can be identified by the use
of forward-looking terminology such as "plans", "targets",
"expects" or "does not expect", "is expected", "an opportunity
exists", "is positioned", "estimates", "intends", "assumes",
"anticipates" or "does not anticipate" or "believes", or variations
of such words and phrases or state that certain actions, events or
results "may", "could", "would", "might", "will" or "will be
taken", "occur" or "be achieved". In addition, any statements that
refer to expectations, projections or other characterizations of
future events or circumstances contain forward-looking information.
Statements containing forward-looking information are not
historical facts but instead represent management's expectations,
estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of
opinions, assumptions and estimates that, while considered
reasonable by Akumin as of the date of this press release, are
subject to known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, level of activity,
performance or achievements to be materially different from those
expressed or implied by such forward-looking information, including
but not limited to the factors described in greater detail in the
"Risk Factors" section of our Annual Information Form available at
www.sedar.com. These factors are not intended to represent a
complete list of the factors that could affect Akumin; however,
these factors should be considered carefully. There can be no
assurance that such estimates and assumptions will prove to be
correct. The forward-looking statements contained in this press
release are made as of the date of this press release, and Akumin
expressly disclaims any obligation to update or alter statements
containing any forward-looking information, or the factors or
assumptions underlying them, whether as a result of new
information, future events or otherwise, except as required by
law.
SOURCE Akumin Inc.